跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 世銘
教授
,
臨床藥學學科
https://orcid.org/0000-0002-0273-4847
電子郵件
smchen
tmu.edu
tw
h-index
720
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2002
2024
每年研究成果
概覽
指紋
網路
專案
(7)
研究成果
(42)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Shih-Ming Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Aristolochic Acid
100%
Nephrotoxicity
89%
Mouse
81%
Lactic Acid
75%
Methylglyoxal
70%
Kidney Disease
70%
Metformin
44%
Nephritis
43%
Chitosan
43%
Diabetes Mellitus
36%
Gentamicin
33%
Cohort Study
32%
Kidney Injury
29%
High Performance Liquid Chromatography
28%
Creatinine
23%
Inbred Mouse Strain
23%
Pharmacokinetics
21%
Streptozotocin
21%
Biological Marker
18%
Microalbuminuria
14%
Mouse Model
12%
Non Insulin Dependent Diabetes Mellitus
12%
C3H/He Mouse
12%
End Stage Renal Disease
12%
Saponin
12%
6 N Carboxymethyllysine
10%
4 Aminohippuric Acid
10%
Lipoprotein Lipase
10%
Beers Criteria
10%
Saikosaponin C
10%
Iron Deficiency Anemia
10%
2,5-Dimethoxy-4-iodoamphetamine
10%
Disorders of Mitochondrial Functions
10%
Statin (Protein)
10%
Glyoxalase
10%
Bupleurum
10%
Saikosaponin
10%
3 Hydroxybutyric Acid
10%
Inducible Nitric Oxide Synthase
10%
Ginsenoside Rg 1
10%
Pancreatic Lipase
10%
Heparin
10%
Atorvastatin
10%
Nitric Oxide
10%
Prednisolone
10%
Inulin
10%
Lysine
10%
Incretin
10%
Colchicine
10%
Cisplatin
10%
Medicine and Dentistry
Cohort Analysis
32%
Glycon
32%
Diabetes Mellitus
23%
Nephritic Syndrome
21%
Nephrotoxicity
21%
Aristolochic Acid
21%
Kidney Function
12%
Maturity Onset Diabetes of the Young
12%
Diagnosis
11%
Chinese Herbal Medicine
10%
End Stage Renal Disease
10%
Saikosaponin C
10%
Kampo
10%
Patient with Type 2 Diabetes
10%
4 Iodo 2,5 Dimethoxyamphetamine
10%
Drug Therapy
10%
Chitosan
10%
Lactic Acid
10%
Ginsenoside Rg 1
10%
Systematic Review
10%
Meta-Analysis
10%
Methylglyoxal
10%
Disorders of Mitochondrial Functions
10%
Incretin
10%
Colchicine
10%
Gentamicin
10%
Nephropathy
8%
Glomerulus Basement Membrane
7%
C57BL/6
7%
Interstitial Nephritis
7%
Tuberculosis
7%
Ginseng Extract
6%
Hazard Ratio
6%
Group Therapy
5%
Urinary System
5%
